IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$535.54 USD
+1.23 (0.23%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $535.67 +0.13 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IDXX 535.54 +1.23(0.23%)
Will IDXX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IDXX
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Other News for IDXX
Here are the major earnings before the open Monday
IDEXX Laboratories Q2 2025 Earnings Preview
Earnings Outlook For IDEXX Laboratories
Baron Focused Growth Fund Q2 2025 Shareholder Letter
Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market ...